Skip to main content
VCbacked
Log inGet Started

Tellus Therapeutics

Hillsborough, United States

Tellus Therapeutics develops novel small molecules derived from human maternal breast milk.

$16.0M raised
Feb 2023
Venture - Series Unknown
Biotechnology

Top Investors

MassChallengeXontogenyNorth Carolina Biotechnology CenterOne North Carolina Small Business Program

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tellus Therapeutics

How much funding has Tellus Therapeutics raised?
Tellus Therapeutics has raised $16.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2023.
Who are Tellus Therapeutics's investors?
Tellus Therapeutics's investors include MassChallenge, Xontogeny, North Carolina Biotechnology Center, One North Carolina Small Business Program.
Where is Tellus Therapeutics headquartered?
Tellus Therapeutics is headquartered in Hillsborough, United States.
What does Tellus Therapeutics do?
Tellus Therapeutics develops novel small molecules derived from human maternal breast milk.
What stage is Tellus Therapeutics at?
Tellus Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Tellus Therapeutics — Funding & Investors." VCBacked, February 21, 2023, https://www.vcbacked.co/company/tellus-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2023). Tellus Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/tellus-therapeutics
Wikipedia (cite web)
{{cite web |title=Tellus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tellus-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong